CervoMed CRVO
NASDAQ CRVO
$2.93 -0.04 (-1.35%)
At close: Oct 1, 2026 · 4:00 PM EDT

CervoMed (CRVO) Preferred Stock Liabilities (2022)

Updated

CervoMed (CRVO) posted Preferred Stock Liabilities of $24.29 million for Q4 2022.

Analysis

CervoMed (CRVO) Preferred Stock Liabilities (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 CervoMed 30.43 Mn 30.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 24.29 Mn
API Access

CervoMed Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CRVO&period=max&api_key=YOUR_API_KEY